Global NASH Therapeutic Drugs Market Insights and Forecast to 2031

Report ID: 1639291 | Published Date: Jan 2025 | No. of Page: 96 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global NASH Therapeutic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Vitamin E and Pioglitazone
        1.2.3 Ocaliva
        1.2.4 Elafibranor
        1.2.5 Selonsertib and Cenicriviroc
    1.3 Market by Application
        1.3.1 Global NASH Therapeutic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacy
        1.3.3 Online Provider
        1.3.4 Retail Pharmacy
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global NASH Therapeutic Drugs Market Perspective (2017-2028)
    2.2 NASH Therapeutic Drugs Growth Trends by Region
        2.2.1 NASH Therapeutic Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 NASH Therapeutic Drugs Historic Market Size by Region (2017-2022)
        2.2.3 NASH Therapeutic Drugs Forecasted Market Size by Region (2023-2028)
    2.3 NASH Therapeutic Drugs Market Dynamics
        2.3.1 NASH Therapeutic Drugs Industry Trends
        2.3.2 NASH Therapeutic Drugs Market Drivers
        2.3.3 NASH Therapeutic Drugs Market Challenges
        2.3.4 NASH Therapeutic Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top NASH Therapeutic Drugs Players by Revenue
        3.1.1 Global Top NASH Therapeutic Drugs Players by Revenue (2017-2022)
        3.1.2 Global NASH Therapeutic Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global NASH Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by NASH Therapeutic Drugs Revenue
    3.4 Global NASH Therapeutic Drugs Market Concentration Ratio
        3.4.1 Global NASH Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by NASH Therapeutic Drugs Revenue in 2021
    3.5 NASH Therapeutic Drugs Key Players Head office and Area Served
    3.6 Key Players NASH Therapeutic Drugs Product Solution and Service
    3.7 Date of Enter into NASH Therapeutic Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 NASH Therapeutic Drugs Breakdown Data by Type
    4.1 Global NASH Therapeutic Drugs Historic Market Size by Type (2017-2022)
    4.2 Global NASH Therapeutic Drugs Forecasted Market Size by Type (2023-2028)
5 NASH Therapeutic Drugs Breakdown Data by Application
    5.1 Global NASH Therapeutic Drugs Historic Market Size by Application (2017-2022)
    5.2 Global NASH Therapeutic Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America NASH Therapeutic Drugs Market Size (2017-2028)
    6.2 North America NASH Therapeutic Drugs Market Size by Type
        6.2.1 North America NASH Therapeutic Drugs Market Size by Type (2017-2022)
        6.2.2 North America NASH Therapeutic Drugs Market Size by Type (2023-2028)
        6.2.3 North America NASH Therapeutic Drugs Market Share by Type (2017-2028)
    6.3 North America NASH Therapeutic Drugs Market Size by Application
        6.3.1 North America NASH Therapeutic Drugs Market Size by Application (2017-2022)
        6.3.2 North America NASH Therapeutic Drugs Market Size by Application (2023-2028)
        6.3.3 North America NASH Therapeutic Drugs Market Share by Application (2017-2028)
    6.4 North America NASH Therapeutic Drugs Market Size by Country
        6.4.1 North America NASH Therapeutic Drugs Market Size by Country (2017-2022)
        6.4.2 North America NASH Therapeutic Drugs Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe NASH Therapeutic Drugs Market Size (2017-2028)
    7.2 Europe NASH Therapeutic Drugs Market Size by Type
        7.2.1 Europe NASH Therapeutic Drugs Market Size by Type (2017-2022)
        7.2.2 Europe NASH Therapeutic Drugs Market Size by Type (2023-2028)
        7.2.3 Europe NASH Therapeutic Drugs Market Share by Type (2017-2028)
    7.3 Europe NASH Therapeutic Drugs Market Size by Application
        7.3.1 Europe NASH Therapeutic Drugs Market Size by Application (2017-2022)
        7.3.2 Europe NASH Therapeutic Drugs Market Size by Application (2023-2028)
        7.3.3 Europe NASH Therapeutic Drugs Market Share by Application (2017-2028)
    7.4 Europe NASH Therapeutic Drugs Market Size by Country
        7.4.1 Europe NASH Therapeutic Drugs Market Size by Country (2017-2022)
        7.4.2 Europe NASH Therapeutic Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific NASH Therapeutic Drugs Market Size (2017-2028)
    8.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Type
        8.2.1 Asia-Pacific NASH Therapeutic Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific NASH Therapeutic Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific NASH Therapeutic Drugs Market Size by Application
        8.3.1 Asia-Pacific NASH Therapeutic Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific NASH Therapeutic Drugs Market Share by Application (2017-2028)
    8.4 Asia-Pacific NASH Therapeutic Drugs Market Size by Region
        8.4.1 Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America NASH Therapeutic Drugs Market Size (2017-2028)
    9.2 Latin America NASH Therapeutic Drugs Market Size by Type
        9.2.1 Latin America NASH Therapeutic Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America NASH Therapeutic Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America NASH Therapeutic Drugs Market Share by Type (2017-2028)
    9.3 Latin America NASH Therapeutic Drugs Market Size by Application
        9.3.1 Latin America NASH Therapeutic Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America NASH Therapeutic Drugs Market Size by Application (2023-2028)
        9.3.3 Latin America NASH Therapeutic Drugs Market Share by Application (2017-2028)
    9.4 Latin America NASH Therapeutic Drugs Market Size by Country
        9.4.1 Latin America NASH Therapeutic Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America NASH Therapeutic Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa NASH Therapeutic Drugs Market Size (2017-2028)
    10.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Type
        10.2.1 Middle East & Africa NASH Therapeutic Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa NASH Therapeutic Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa NASH Therapeutic Drugs Market Size by Application
        10.3.1 Middle East & Africa NASH Therapeutic Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa NASH Therapeutic Drugs Market Share by Application (2017-2028)
    10.4 Middle East & Africa NASH Therapeutic Drugs Market Size by Country
        10.4.1 Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Allergan Plc (Tobira)
        11.1.1 Allergan Plc (Tobira) Company Details
        11.1.2 Allergan Plc (Tobira) Business Overview
        11.1.3 Allergan Plc (Tobira) NASH Therapeutic Drugs Introduction
        11.1.4 Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2017-2022)
        11.1.5 Allergan Plc (Tobira) Recent Developments
    11.2 Bristol Myers Squibb
        11.2.1 Bristol Myers Squibb Company Details
        11.2.2 Bristol Myers Squibb Business Overview
        11.2.3 Bristol Myers Squibb NASH Therapeutic Drugs Introduction
        11.2.4 Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2017-2022)
        11.2.5 Bristol Myers Squibb Recent Developments
    11.3 Galmed Pharmaceuticals
        11.3.1 Galmed Pharmaceuticals Company Details
        11.3.2 Galmed Pharmaceuticals Business Overview
        11.3.3 Galmed Pharmaceuticals NASH Therapeutic Drugs Introduction
        11.3.4 Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2017-2022)
        11.3.5 Galmed Pharmaceuticals Recent Developments
    11.4 Genfit SA
        11.4.1 Genfit SA Company Details
        11.4.2 Genfit SA Business Overview
        11.4.3 Genfit SA NASH Therapeutic Drugs Introduction
        11.4.4 Genfit SA Revenue in NASH Therapeutic Drugs Business (2017-2022)
        11.4.5 Genfit SA Recent Developments
    11.5 Gilead Sciences, Inc.
        11.5.1 Gilead Sciences, Inc. Company Details
        11.5.2 Gilead Sciences, Inc. Business Overview
        11.5.3 Gilead Sciences, Inc. NASH Therapeutic Drugs Introduction
        11.5.4 Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2017-2022)
        11.5.5 Gilead Sciences, Inc. Recent Developments
    11.6 Intercept Pharmaceuticals, Inc.
        11.6.1 Intercept Pharmaceuticals, Inc. Company Details
        11.6.2 Intercept Pharmaceuticals, Inc. Business Overview
        11.6.3 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Introduction
        11.6.4 Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2017-2022)
        11.6.5 Intercept Pharmaceuticals, Inc. Recent Developments
    11.7 Zydus Cadila
        11.7.1 Zydus Cadila Company Details
        11.7.2 Zydus Cadila Business Overview
        11.7.3 Zydus Cadila NASH Therapeutic Drugs Introduction
        11.7.4 Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2017-2022)
        11.7.5 Zydus Cadila Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global NASH Therapeutic Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Vitamin E and Pioglitazone
    Table 3. Key Players of Ocaliva
    Table 4. Key Players of Elafibranor
    Table 5. Key Players of Selonsertib and Cenicriviroc
    Table 6. Global NASH Therapeutic Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global NASH Therapeutic Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global NASH Therapeutic Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global NASH Therapeutic Drugs Market Share by Region (2017-2022)
    Table 10. Global NASH Therapeutic Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global NASH Therapeutic Drugs Market Share by Region (2023-2028)
    Table 12. NASH Therapeutic Drugs Market Trends
    Table 13. NASH Therapeutic Drugs Market Drivers
    Table 14. NASH Therapeutic Drugs Market Challenges
    Table 15. NASH Therapeutic Drugs Market Restraints
    Table 16. Global NASH Therapeutic Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global NASH Therapeutic Drugs Revenue Share by Players (2017-2022)
    Table 18. Global Top NASH Therapeutic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NASH Therapeutic Drugs as of 2021)
    Table 19. Ranking of Global Top NASH Therapeutic Drugs Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by NASH Therapeutic Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players NASH Therapeutic Drugs Product Solution and Service
    Table 23. Date of Enter into NASH Therapeutic Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global NASH Therapeutic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global NASH Therapeutic Drugs Revenue Market Share by Type (2017-2022)
    Table 27. Global NASH Therapeutic Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global NASH Therapeutic Drugs Revenue Market Share by Type (2023-2028)
    Table 29. Global NASH Therapeutic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global NASH Therapeutic Drugs Revenue Share by Application (2017-2022)
    Table 31. Global NASH Therapeutic Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global NASH Therapeutic Drugs Revenue Share by Application (2023-2028)
    Table 33. North America NASH Therapeutic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America NASH Therapeutic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America NASH Therapeutic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America NASH Therapeutic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America NASH Therapeutic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America NASH Therapeutic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe NASH Therapeutic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe NASH Therapeutic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe NASH Therapeutic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe NASH Therapeutic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe NASH Therapeutic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe NASH Therapeutic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific NASH Therapeutic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific NASH Therapeutic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific NASH Therapeutic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific NASH Therapeutic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific NASH Therapeutic Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific NASH Therapeutic Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America NASH Therapeutic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America NASH Therapeutic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America NASH Therapeutic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America NASH Therapeutic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America NASH Therapeutic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America NASH Therapeutic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa NASH Therapeutic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa NASH Therapeutic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa NASH Therapeutic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa NASH Therapeutic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa NASH Therapeutic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa NASH Therapeutic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Allergan Plc (Tobira) Company Details
    Table 64. Allergan Plc (Tobira) Business Overview
    Table 65. Allergan Plc (Tobira) NASH Therapeutic Drugs Product
    Table 66. Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 67. Allergan Plc (Tobira) Recent Developments
    Table 68. Bristol Myers Squibb Company Details
    Table 69. Bristol Myers Squibb Business Overview
    Table 70. Bristol Myers Squibb NASH Therapeutic Drugs Product
    Table 71. Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 72. Bristol Myers Squibb Recent Developments
    Table 73. Galmed Pharmaceuticals Company Details
    Table 74. Galmed Pharmaceuticals Business Overview
    Table 75. Galmed Pharmaceuticals NASH Therapeutic Drugs Product
    Table 76. Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 77. Galmed Pharmaceuticals Recent Developments
    Table 78. Genfit SA Company Details
    Table 79. Genfit SA Business Overview
    Table 80. Genfit SA NASH Therapeutic Drugs Product
    Table 81. Genfit SA Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 82. Genfit SA Recent Developments
    Table 83. Gilead Sciences, Inc. Company Details
    Table 84. Gilead Sciences, Inc. Business Overview
    Table 85. Gilead Sciences, Inc. NASH Therapeutic Drugs Product
    Table 86. Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 87. Gilead Sciences, Inc. Recent Developments
    Table 88. Intercept Pharmaceuticals, Inc. Company Details
    Table 89. Intercept Pharmaceuticals, Inc. Business Overview
    Table 90. Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Product
    Table 91. Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 92. Intercept Pharmaceuticals, Inc. Recent Developments
    Table 93. Zydus Cadila Company Details
    Table 94. Zydus Cadila Business Overview
    Table 95. Zydus Cadila NASH Therapeutic Drugs Product
    Table 96. Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 97. Zydus Cadila Recent Developments
    Table 98. Research Programs/Design for This Report
    Table 99. Key Data Information from Secondary Sources
    Table 100. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global NASH Therapeutic Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Vitamin E and Pioglitazone Features
    Figure 3. Ocaliva Features
    Figure 4. Elafibranor Features
    Figure 5. Selonsertib and Cenicriviroc Features
    Figure 6. Global NASH Therapeutic Drugs Market Share by Application: 2021 VS 2028
    Figure 7. Hospital Pharmacy Case Studies
    Figure 8. Online Provider Case Studies
    Figure 9. Retail Pharmacy Case Studies
    Figure 10. NASH Therapeutic Drugs Report Years Considered
    Figure 11. Global NASH Therapeutic Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global NASH Therapeutic Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global NASH Therapeutic Drugs Market Share by Region: 2021 VS 2028
    Figure 14. Global NASH Therapeutic Drugs Market Share by Players in 2021
    Figure 15. Global Top NASH Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NASH Therapeutic Drugs as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by NASH Therapeutic Drugs Revenue in 2021
    Figure 17. North America NASH Therapeutic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America NASH Therapeutic Drugs Market Size Market Share by Type (2017-2028)
    Figure 19. North America NASH Therapeutic Drugs Market Size Market Share by Application (2017-2028)
    Figure 20. North America NASH Therapeutic Drugs Market Size Share by Country (2017-2028)
    Figure 21. United States NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe NASH Therapeutic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe NASH Therapeutic Drugs Market Size Market Share by Type (2017-2028)
    Figure 25. Europe NASH Therapeutic Drugs Market Size Market Share by Application (2017-2028)
    Figure 26. Europe NASH Therapeutic Drugs Market Size Share by Country (2017-2028)
    Figure 27. Germany NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific NASH Therapeutic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific NASH Therapeutic Drugs Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific NASH Therapeutic Drugs Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific NASH Therapeutic Drugs Market Size Share by Region (2017-2028)
    Figure 37. China NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America NASH Therapeutic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America NASH Therapeutic Drugs Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America NASH Therapeutic Drugs Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America NASH Therapeutic Drugs Market Size Share by Country (2017-2028)
    Figure 47. Mexico NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa NASH Therapeutic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa NASH Therapeutic Drugs Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa NASH Therapeutic Drugs Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa NASH Therapeutic Drugs Market Size Share by Country (2017-2028)
    Figure 53. Turkey NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Allergan Plc (Tobira) Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)
    Figure 57. Bristol Myers Squibb Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)
    Figure 58. Galmed Pharmaceuticals Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)
    Figure 59. Genfit SA Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)
    Figure 60. Gilead Sciences, Inc. Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)
    Figure 61. Intercept Pharmaceuticals, Inc. Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)
    Figure 62. Zydus Cadila Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allergan Plc (Tobira)
Bristol Myers Squibb
Galmed Pharmaceuticals
Genfit SA
Gilead Sciences, Inc.
Intercept Pharmaceuticals, Inc.
Zydus Cadila
Frequently Asked Questions
NASH Therapeutic Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
NASH Therapeutic Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
NASH Therapeutic Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

GLP-1R Agonist

GLP-1R Agonist market is segmented by players, region (country), by Type and by Application. Play ... Read More